Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Assessing Progress in Management of Diabetes, Diabetic Retinopathy
With an estimated 642 million patients projected to be affected by diabetes globally by 2040, an article by Modern Retina™ highlighted the progress made so far in understanding the epidemiology, natural history, causal mechanisms, and treatments for one of most common complications associated with the condition, diabetic retinopathy (DR).
Affecting 49% of patients with diabetes, the prevention of DR was indicated as improving across western Europe and high-income areas of North America, potentially due to nationwide DR screening programs, improved glycemic control, and better therapies.
For underserved communities, the use of hand-held devices may work to help monitor patients, although a lack of patient awareness continues to be a substantial contributor to poor outcomes and nonadherence to eye care guidelines.
Why Nurses May Be Best Suited to Inject Dexamethasone Implants
As one of the most commonly performed procedures in ophthalmology, intravitreal injections are projected to increase, with an aging population requiring treatment for wet age-related macular degeneration and a rising diabetes population who may develop diabetic maculopathy.
To meet this increasing demand, an article by Modern Retina™ highlights the efficacy shown in prior studies indicating that nurses and other allied health care professionals, including optometrists and orthoptists, can safely inject anti–vascular endothelial growth factor (VEGF).
Although the United Kingdom is at the forefront of adopting the nurse injector as a model for service delivery, efforts to include dexamethasone, a process involving a larger needle (19 gauge) than those use for anti-VEGF injections (30 gauge), has so far been met with apprehension.
If injection qualifications for intravitreal injections were expanded to nurses, the article highlights the significant cost savings and wait time decrease that could result, as well as a maintained level of safety.
Applicability of Video Content Technology in Ophthalmology Practice Care
Providing ophthalmologists with worldwide access to high-value, short-form video content, Ocular Innovations’ Human Experience Platform was spotlighted in a recent article by Ophthalmology Times® as a potential way to optimize the overall patient experience.
The platform works to push videos directly to patients’ smartphones without the need to download an app, access email, or log in to any account. Allowing patients to view videos at their leisure from anywhere, the platform informs patients on what to expect in surgical processes, treatment options, and recovery.
The short-form video content library applies across a variety of vision topics, including cataracts, LASIK and refractive surgeries, glaucoma, macular degeneration, diabetic retinopathy, and more.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More